UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SN-26-162

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AN13

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a Special Notice (ARPA-H-SN-26-162) to inform the scientific and research community about the launch of a new program titled "UNifying Imaging with QUantum Entanglement (UNIQUE)." This notice serves as an invitation to a Proposers' Day event, which is scheduled for 8:30am Eastern Time on October 16, 2026, at the Executive Conference Center (ECC), located at 4075 Wilson Blvd, Suite 300, Arlington, VA 22203. The UNIQUE program is positioned within the NAICS classification 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and is further identified by Product Service Code AN13. The primary objective of this initiative is to advance research and development efforts in biotechnology, with a specific focus on leveraging quantum entanglement to unify imaging technologies. While the notice does not provide detailed technical requirements or deliverables, it signals ARPA-H’s intent to foster innovative solutions and collaborations in this emerging field. The Proposers' Day is designed to engage potential proposers, offering them an opportunity to learn more about the program’s scope, intended outcomes, and participation requirements. Attendees will receive further details through the attached UNIQUE-SN-ARPA-H-SN-26-162 document, and a Lightning Talk Template is provided to facilitate concise presentations and idea sharing. This event is particularly relevant for organizations and individuals specializing in biotechnology research and development, who are interested in contributing to the advancement of quantum-enabled imaging technologies. The contracting entity for this opportunity is ARPA-H, a federal office within the NIH, and all inquiries should be directed to the UNIQUE Team via email at [email protected]. The notice remains active, with a response deadline set for October 14, 2026, at 12:10pm ET. Interested parties are encouraged to review the full notice and attachments via the official SAM.gov listing (Opportunity ID: 043c012445944ed8ba80b5d50433772d) for comprehensive information and participation instructions. This Special Notice does not specify procurement set-aside requirements or special considerations, as it primarily serves to announce the Proposers' Day and facilitate early engagement with the scientific community. Contractors evaluating this opportunity should consider their expertise in biotechnology R&D and their capacity to contribute to quantum imaging advancements, as these elements are likely to remain central throughout the program’s lifecycle.